Common Stock
- Symbol
- HRZN
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 1.01, 9.01 · 8-K
Horizon Technology Finance Corporation
HRZNNASDAQEQUITYCurrent
Entry into a Material Definitive Agreement
Section 1 Registrant's Business and Operations ───────────────────────────────────────────────────────────── Item 1.01 Entry into a Material Definitive Agreement On September 2, 2026 (the “2026 Amendment Date”), Horizon Funding II, LLC (the “Issuer”), a Delaware limited liability company and wholly owned subsidiary of Horizon Technology Finance Corporation (the “Company”), executed that certain Se…
Company context
Horizon Technology Finance Corporation (NASDAQ: HRZN) is a leading specialty finance company that provides secured loans to venture capital-backed companies in the technology, life-science, healthcare information & services, and sustainability industries. Horizon is externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital LLC.
Current securities
Historical securities (2)
Registered securities in this filing
HORIZON TECHNOLOGY FINANCE CORPORATION · 8-K · Filed 2026-09-09
6.25% Notes due 2027
- Symbol
- HTFC
- Exchange
- NYSE
- Classification
- DEBT
- Status
- Current
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Section 1 Registrant's Business and Operations
─────────────────────────────────────────────────────────────
Item 1.01 Entry into a Material Definitive Agreement
On September 2, 2026 (the “2026 Amendment Date”), Horizon Funding II, LLC (the “Issuer”), a Delaware limited liability company and wholly owned subsidiary of Horizon Technology Finance Corporation (the “Company”), executed that certain Second Supplemental Indenture by and among the Issuer and U.S. Bank Trust Company, National Association (the “Trustee”) (the “Second Supplemental Indenture”), which amended that certain Indenture by and among the Issuer, the Trustee and U.S. Bank National Association (“U.S. Bank”), dated as of June 21, 2024, as previously amended by the First Supplemental Indenture, dated as of May 23, 2025 (the “Indenture”). The Second Supplemental Indenture extended the “Legal Final Payment Date” to December 10, 2035. Concurrently, the Issuer entered into that certain Second Amended and Restated Note Funding Agreement by and among the Issuer and the initial purchasers (the “Second A&R Note Funding Agreement”), which amended and restated in its entirety the Amended and Restated Note Funding Agreement, dated as of May 23, 2025. In addition, on September 2, 2026, the Company entered into that certain Amendment No. 2 to Sale and Servicing Agreement by and among the Issuer, the Company, the Trustee and U.S. Bank (the “Amendment No. 2”), which further amended that certain Sale and Servicing Agreement by and among the Issuer, the Company, the Trustee and U.S. Bank, dated as of June 21, 2024, as previously amended by Amendment No. 1 to the Sale and Servicing Agreement (the “Sale and Servicing Agreement”).
The description of the documentation related to the Second A&R Note Funding Agreement, the Amendment No. 2 and the Second Supplemental Indenture contained in this Current Report on Form 8-K is only a summary of the material terms of the Second A&R Note Funding Agreement, the Amendment No. 2 and the Second Supplemental Indenture and is qualified in its entirety by the terms of the Second A&R Note Funding Agreement, the Amendment No. 2 and the Second Supplemental Indenture filed as exhibits hereto, which is incorporated herein by reference.